# Adempas

NDC: 50419-252
Generic name: riociguat
Labeler / Manufacturer: Bayer HealthCare Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20131008

FDA application: NDA204819

## Active ingredients

- RIOCIGUAT: 1.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50419-252"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50419-252
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b57509a-3d5d-41d4-8fed-1471e26372a3